PTC Therapeutics, Inc. Expected to Earn FY2028 Earnings of $0.39 Per Share (NASDAQ:PTCT)
PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – Analysts at Leerink Partnrs issued their FY2028 EPS estimates for PTC Therapeutics in a research report issued on Monday, January 15th. Leerink Partnrs analyst J. Schwartz forecasts that the biopharmaceutical company will earn $0.39 per share for the year. The consensus estimate for PTC Therapeutics’ current full-year […]
More Stories
Neo Price Reaches $10.52 (NEO)
Neo (NEO) traded 1.5% higher against the dollar during the 24-hour period ending at 17:00 PM ET on October 18th....
Ankr Reward-Bearing Staked ETH (aETHc) Trading 9.2% Higher Over Last Week
Ankr Reward-Bearing Staked ETH (aETHc) traded up 2.1% against the U.S. dollar during the 1-day period ending at 17:00 PM...
KOK Trading 36.3% Lower Over Last Week (KOK)
KOK (KOK) traded 1.3% higher against the U.S. dollar during the 1 day period ending at 17:00 PM Eastern on...
Waltonchain One Day Trading Volume Reaches $0.02 (WTC)
Waltonchain (WTC) traded 0% higher against the US dollar during the 24-hour period ending at 17:00 PM E.T. on October...
MOG Coin Self Reported Market Cap Reaches $814.80 Million (MOG)
MOG Coin (MOG) traded 6.8% higher against the US dollar during the 1-day period ending at 17:00 PM ET on...
V Square Quantitative Management LLC Has $2.08 Million Stock Position in Intel Co. (NASDAQ:INTC)
V Square Quantitative Management LLC lifted its holdings in Intel Co. (NASDAQ:INTC – Free Report) by 25.1% in the 3rd...